February 21st - 23rd | Hilton Boston Logan Airport
Applied BioMath Presence:
Presentation Title: More than the Sum of Their Parts: Integrating data and knowledge of ADCs in a QSP platform model to predict efficacy and toxicity
- There are 12 approved ADCs targeting various solid and hematological malignancies and while the ADC concept may be simple, the application is difficult.
- Quantitative systems pharmacology modeling helps guide ADC design and development by creating a platform to guide design properties and understand therapeutic window.
- Here we will present a consolidated ADC QSP platform model predicting ADC efficacy and hematological toxicities.
Presenter: Josh Apgar, PhD, Co-Founder and CSO of Applied BioMath
Day and Time: Wednesday, February 22nd | 2:00pm ET